Solutions For RealSolutions For Real
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Seven Important Points About Part D Drug Plans And Pharmacies

June 18, 2025

10 Money-Saving Summer Dates to Mark on Your Calendar Now

June 18, 2025

5 Steps to Apply for Social Security (and When to Do It)

June 18, 2025
Facebook Twitter Instagram
Trending
  • Seven Important Points About Part D Drug Plans And Pharmacies
  • 10 Money-Saving Summer Dates to Mark on Your Calendar Now
  • 5 Steps to Apply for Social Security (and When to Do It)
  • Americans increasingly abandon financial planning as economic pressures mount
  • Bezos-Sánchez Wedding Draws Business, Protests to Venice
  • Meta Plans to Release New Oakley, Prada AI Smart Glasses
  • American Express set to unveil game-changing update to its elite Platinum cards
  • Chris Hughes’ American Economic History
Wednesday, June 18
Facebook Twitter Instagram
Solutions For RealSolutions For Real
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
Solutions For RealSolutions For Real
Home » This health care giant has ‘unlocked potential’ after a recent spinoff, RBC says
News

This health care giant has ‘unlocked potential’ after a recent spinoff, RBC says

News RoomBy News RoomOctober 5, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

Johnson & Johnson is a buy after the company’s consumer business spinoff earlier this year, according to RBC Capital Markets. The firm initiated Johnson & Johnson with an outperform rating and $178 price target, which suggests shares can climb about 14.5% from Wednesday’s close. The company spun off its consumer health business Kenvue earlier this year. This separation has “unlocked potential” for Johnson & Johnson going forward, analyst Shagun Singh said. “JNJ’s value-accretive consumer separation: (1) positions it uniquely as the only global healthcare company with Pharma and MedTech under a single portfolio, allowing for exclusive focus on innovation and enhanced productivity; (2) positions it for higher revenue and margins; and (3) leaves room to monetize its retained 9.5% stake in the consumer asset,” he added. Singh also said the company’s pharma franchise is poised to deliver competitive growth and that its medtech division is on pace to achieve “top-tier growth and profitability.” Its pharmaceutical sales are aided by its pipeline that includes five therapies worth more than $5 billion in revenue potential and twelve therapies with more than $1 billion potential. The medtech division — which provides devices for surgeries, orthopedics and vision — had jumped in the second quarter as demand rebounded for nonurgent surgeries among older adults after the Covid pandemic. This division has a “clear winning strategy” in gaining sales from growing markets and focusing on innovative products in areas such as surgical and orthopedic robotics and heart failure. The analyst added that Johnson & Johnson is trading below its historical multiples despite its improved financial profile since its Kenvue spinoff and that the company has potential upside from further M & A activity. — CNBC’s Michael Bloom contributed to this report.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Lucid shares tumble following public offering of nearly 262.5 million shares

News October 17, 2024

Harris distances herself from Biden, bashes Trump in tense Fox News interview

News October 17, 2024

Alibaba’s international arm says its new AI translation tool beats Google and ChatGPT

News October 16, 2024

I bought a $54,000 abandoned house in Japan and turned it into a luxury Airbnb—take a look inside

News October 16, 2024

Trump’s crypto coin goes on sale with Election Day just three weeks out

News October 15, 2024

Cramer’s Lightning Round: Uranium Energy is ‘the real deal’

News October 15, 2024
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

10 Money-Saving Summer Dates to Mark on Your Calendar Now

June 18, 20250 Views

5 Steps to Apply for Social Security (and When to Do It)

June 18, 20250 Views

Americans increasingly abandon financial planning as economic pressures mount

June 18, 20250 Views

Bezos-Sánchez Wedding Draws Business, Protests to Venice

June 18, 20250 Views
Don't Miss

Meta Plans to Release New Oakley, Prada AI Smart Glasses

By News RoomJune 18, 2025

Following the unexpected success of the Ray-Ban Meta smart glasses, which have sold two million…

American Express set to unveil game-changing update to its elite Platinum cards

June 17, 2025

Chris Hughes’ American Economic History

June 17, 2025

Homes With These 3 Architecture Styles Are Gaining Value Fastest

June 17, 2025
About Us
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

Seven Important Points About Part D Drug Plans And Pharmacies

June 18, 2025

10 Money-Saving Summer Dates to Mark on Your Calendar Now

June 18, 2025

5 Steps to Apply for Social Security (and When to Do It)

June 18, 2025
Most Popular

A Deep Dive on the County Level

September 7, 20231 Views

Seven Important Points About Part D Drug Plans And Pharmacies

June 18, 20250 Views

10 Money-Saving Summer Dates to Mark on Your Calendar Now

June 18, 20250 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Solutions For Real. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.